Difference between revisions of "Part:BBa K2624000:Experience"
JunQing Flag (Talk | contribs) |
|||
| Line 5: | Line 5: | ||
===Applications of BBa_K2624000=== | ===Applications of BBa_K2624000=== | ||
| − | + | To improve the selectivity of our therapy system, we utilize hTERT, the cancer-specific promoter, and HULC, the HCC-specific promoter, to open an AND-gated system to target HCC (Hepatocellular carcinoma). | |
===User Reviews=== | ===User Reviews=== | ||
<!-- DON'T DELETE --><partinfo>BBa_K2624000 StartReviews</partinfo> | <!-- DON'T DELETE --><partinfo>BBa_K2624000 StartReviews</partinfo> | ||
Revision as of 17:21, 17 October 2018
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K2624000
To improve the selectivity of our therapy system, we utilize hTERT, the cancer-specific promoter, and HULC, the HCC-specific promoter, to open an AND-gated system to target HCC (Hepatocellular carcinoma).
User Reviews
UNIQ73fec95d339eb97f-partinfo-00000000-QINU UNIQ73fec95d339eb97f-partinfo-00000001-QINU